You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

FOSPHENYTOIN SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Fosphenytoin Sodium, and when can generic versions of Fosphenytoin Sodium launch?

Fosphenytoin Sodium is a drug marketed by Am Regent, Amneal, Apotex Inc, Dr Reddys, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hikma Farmaceutica, Hospira, Norvium Bioscience, Sun Pharm, and Wockhardt. and is included in fourteen NDAs.

The generic ingredient in FOSPHENYTOIN SODIUM is fosphenytoin sodium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the fosphenytoin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fosphenytoin Sodium

A generic version of FOSPHENYTOIN SODIUM was approved as fosphenytoin sodium by FRESENIUS KABI USA on August 6th, 2007.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FOSPHENYTOIN SODIUM?
  • What are the global sales for FOSPHENYTOIN SODIUM?
  • What is Average Wholesale Price for FOSPHENYTOIN SODIUM?
Drug patent expirations by year for FOSPHENYTOIN SODIUM
Recent Clinical Trials for FOSPHENYTOIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NobelpharmaPhase 3
Shaheed Zulfiqar Ali Bhutto Medical UniversityN/A
Institute of Medical Sciences of the Banaras Hindu University (BHU),IndiaPhase 2

See all FOSPHENYTOIN SODIUM clinical trials

US Patents and Regulatory Information for FOSPHENYTOIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent FOSPHENYTOIN SODIUM fosphenytoin sodium INJECTABLE;INJECTION 078277-001 Aug 6, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gland Pharma Ltd FOSPHENYTOIN SODIUM fosphenytoin sodium INJECTABLE;INJECTION 214926-001 Oct 13, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex Inc FOSPHENYTOIN SODIUM fosphenytoin sodium INJECTABLE;INJECTION 078126-001 Aug 6, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience FOSPHENYTOIN SODIUM fosphenytoin sodium INJECTABLE;INJECTION 078736-001 Jun 8, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma FOSPHENYTOIN SODIUM fosphenytoin sodium INJECTABLE;INJECTION 077481-001 Aug 6, 2007 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wockhardt FOSPHENYTOIN SODIUM fosphenytoin sodium INJECTABLE;INJECTION 078137-001 Aug 6, 2007 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Am Regent FOSPHENYTOIN SODIUM fosphenytoin sodium INJECTABLE;INJECTION 090099-001 May 13, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.